Episode Details
Back to EpisodesCould immunotherapy redefine treatment for Estrogen Receptor positive/HER2 negative breast cancer?
Episode 470
Published 1 year, 6 months ago
Description
A new phase 3 trial demonstrated that adding nivolumab to adjuvant chemotherapy significantly improves outcomes for patients with ER-positive HER2-negative breast cancers. Heavy lifetime cannabis use was associated with reduced brain activity in areas responsible for working memory, suggesting potential long-term cognitive impacts. A study found that EMS clinicians wearing ballistic vests experienced higher rates of workplace violence and increased patient refusal of treatment, particularly among racial and ethnic minority patients.